

Crystal Pharmatech, part of Crystal Group Information
Summary
Crystal Pharmatech, part of Crystal Group, is an independent biotech and pharmaceutical company headquartered in Cranbury, New Jersey. Established in 2010, the firm employs between 200 and 500 professionals and reports annual revenues ranging from $10 million to $50 million.
The company focuses on a comprehensive suite of development services across the drug discovery and manufacturing continuum. Its core capabilities include salt, polymorph, and cocrystal screening; API characterization, process optimization, crystallization, and chiral resolution; preformulation work; amorphous solid dispersion design; formulation development; GMP and commercial manufacturing; and advanced structural techniques such as MicroED and single‑crystal X‑ray diffraction.
Key leaders steer the organization, including Rositza Petrova, Head of US R&D; Robert Wenslow, Vice President Business Development; Viona Wang, Head of Marketing; Eva DENG, CFO & Head of US Operations; Pradeep Pandey, Group Lead for Separation Sciences; and Russell Outcalt on the Scientific Advisory Board. The team also features directors and scientists across research, marketing, and operations.
| Website | crystalpharmatech.com |
| Social Links | |
| Phone Number | 925-558-5040 |
| Industries | |
| Headquarters Address | 3000 Eastpark Blvd, Cranbury, New Jersey, 08512 US |
| Company Size | 200-500 employees |
| Specialities & Services | salt screening, polymorph screening, cocrystal screening, API characterization, API process optimization, API crystallization, chiral resolution, preformulation, amorphous solid dispersion, crystallization development and optimization, Formulation, GMP Manufacturing, Formulation Development, Clinical and Commercial Manufacturing, MicroED, Single Crystal XRD |
| SIC Code | 8731 |
| NAICS Code | 541713 Research and Development in Nanotechnology, 541714 Research and Development in Biotechnology (except Nanobiotechnology), 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) |
| DMA Code | New York Metropolitan Area |
| Founded | 2010 |
| Estimated Annual Revenue | $10M - 50M |
| Operating Status | Independent Company |
| Updated: | 2026-09-11 |
Competitors
Name | Founded | Type | Employees |
|---|---|---|---|
| 2014 | Public Company | 100 - 250 | |
| 2004 | Privately Held | 500 - 1.0K | |
| 2002 | Public Company | 500 - 1.0K | |
| 2004 | Privately Held | 100 - 250 |
Estimated Website Traffic
The chart shows a decline in traffic to the crystalpharmatech.com website. In August, traffic decreased to 634, compared to 1214 in the previous month. The highest traffic in 2026 was recorded in March, reaching 1349 visits.
Workforce Turnover
Number of staff members switched
Departmental Headcount Distribution
Corporate Tenure Analytics
Workforce Experience Insights
6% have been with the company for less than 1 year6% have been with the company for 1 to 2 years13% have been with the company for 3 to 4 years13% have been with the company for 5 to 7 years25% have been with the company for 8 to 10 years38% have been with the company for more than 11 yearsSimilar Companies
FAQ
Data Privacy
GDPR COMPLIANT
SignalHire complies with the General Data Protection Regulation (GDPR). SignalHire follows GDPR requirements, including but not limited to rights of data subjects to access, correct, or delete their personal information and supports the right to be forgotten.
CCPA COMPLIANT
SignalHire is CCPA-compliant and provides California residents the right to know, access, opt out, and request deletion of their personal data.









